Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Withdrawal syndromes.

R Olmedo1, R S Hoffman

  • 1New York City Poison Control Center, New York, USA.

Emergency Medicine Clinics of North America
|April 18, 2000
PubMed
Summary

This review explains substance withdrawal pathophysiology, comparing syndromes from ethanol, sedative-hypnotics, opioids, and baclofen. It also covers patient management and pharmacotherapy strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A response to Zhou et al., regarding thiamine supplementation in altered mental status.

Hospital practice (1995)·2022
Same author

Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias".

Clinical toxicology (Philadelphia, Pa.)·2016
Same author

Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.

Clinical pharmacology and therapeutics·2015
Same author

Retained drugs in the gastrointestinal tracts of deceased victims of oral drug overdose.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup.

Clinical toxicology (Philadelphia, Pa.)·2014

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Medicine

Background:

  • Substance withdrawal syndromes present complex clinical challenges.
  • Understanding the underlying pathophysiology is crucial for effective treatment.
  • Existing research offers insights into various substance withdrawal states.

Purpose of the Study:

  • To elucidate the pathophysiology of substance withdrawal.
  • To compare withdrawal syndromes associated with ethanol, sedative-hypnotics, opioids, and baclofen.
  • To discuss the general management and pharmacotherapy for withdrawal.

Main Methods:

  • Comprehensive review of classic and current research.
  • Comparative analysis of withdrawal syndrome manifestations and evaluations.
  • Synthesis of management and pharmacotherapy approaches.

Main Results:

  • Detailed comparison of withdrawal characteristics across different substance classes.
  • Identification of common and distinct pathophysiological mechanisms.
  • Overview of evidence-based management and pharmacotherapeutic options.

Conclusions:

  • Effective management of substance withdrawal requires understanding specific pathophysiological pathways.
  • Pharmacotherapy plays a vital role in mitigating withdrawal symptoms and preventing complications.
  • Further research can refine treatment strategies for diverse substance withdrawal syndromes.

Related Experiment Videos